(BBC News) Natalie Lisbona - Dr. Talia Cohen Solal, a neuroscientist, is the co-founder and chief executive of Israeli health-tech firm Genetika+. Established in 2018, the company's technology can best match antidepressants to patients, to avoid unwanted side effects and make sure that the prescribed drug works as well as possible. "We can characterize the right medication for each patient the first time" by combining the latest in stem cell technology - the growing of specific human cells - with artificial intelligence (AI) software, says Dr. Cohen Solal. While the technology is currently still in the development stage, Genetika+ intends to launch commercially next year.
2023-04-20 00:00:00Full ArticleBACK Visit the Daily Alert Archive